These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8635356)

  • 1. Posttransplant bronchiolitis obliterans syndrome. Where have we been and where are we going?
    Dauber JH
    Chest; 1996 Apr; 109(4):857-9. PubMed ID: 8635356
    [No Abstract]   [Full Text] [Related]  

  • 2. Are we near to an effective drug treatment for bronchiolitis obliterans?
    Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
    Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation.
    Ailawadi G; Smith PW; Oka T; Wang H; Kozower BD; Daniel TM; Kron IL; Jones DR
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):594-602. PubMed ID: 18329476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome.
    Daud SA; Yusen RD; Meyers BF; Chakinala MM; Walter MJ; Aloush AA; Patterson GA; Trulock EP; Hachem RR
    Am J Respir Crit Care Med; 2007 Mar; 175(5):507-13. PubMed ID: 17158279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation.
    Ross DJ; Lewis MI; Kramer M; Vo A; Kass RM
    Chest; 1997 Nov; 112(5):1175-9. PubMed ID: 9367453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Post-lung transplantation bronchiolitis obliterans].
    Fournier M; Groussard O; Mal H; Sleiman C; Duchatelle JP; Andreassian B; Pariente R
    Rev Mal Respir; 1995; 12(1):5-11. PubMed ID: 7899668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obliterative bronchiolitis.
    Kelly K; Hertz MI
    Clin Chest Med; 1997 Jun; 18(2):319-38. PubMed ID: 9187825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after bronchiolitis obliterans syndrome.
    Yerkovich ST; Hopkins PM; Chambers DC
    Am J Respir Crit Care Med; 2011 Feb; 183(4):554; author reply 554-5. PubMed ID: 21325085
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment.
    Verleden GM
    Monaldi Arch Chest Dis; 2000 Apr; 55(2):140-5. PubMed ID: 10949876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
    Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
    J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil reduces alveolar inflammation, acute rejection and graft loss due to bronchiolitis obliterans syndrome after lung transplantation.
    Speich R; Schneider S; Hofer M; Irani S; Vogt P; Weder W; Boehler A
    Pulm Pharmacol Ther; 2010 Oct; 23(5):445-9. PubMed ID: 20394831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invited commentary.
    Bhorade S
    Ann Thorac Surg; 2014 Jan; 97(1):274-5. PubMed ID: 24384177
    [No Abstract]   [Full Text] [Related]  

  • 15. Obliterative bronchiolitis after lung transplantation.
    Boehler A; Estenne M
    Curr Opin Pulm Med; 2000 Mar; 6(2):133-9. PubMed ID: 10741773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
    Verleden GM; Dupont LJ; Van Raemdonck DE
    Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung-resident mesenchymal stromal cells. A new player in post-transplant bronchiolitis obliterans syndrome?
    Martinu T; Palmer SM; Ortiz LA
    Am J Respir Crit Care Med; 2011 Apr; 183(8):968-70. PubMed ID: 21498820
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation.
    Morrell MR; Despotis GJ; Lublin DM; Patterson GA; Trulock EP; Hachem RR
    J Heart Lung Transplant; 2010 Apr; 29(4):424-31. PubMed ID: 19853479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
    Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W
    Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M; Maurer J; Winton T; Kesten S
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.